Last reviewed · How we verify
NCT03870087
PRECISION GRX Post-Market Study - Japan
trial testing Robotic-assisted PCI in Coronary Artery Disease in 242 participants. Completed in 9 October 2020.
9 October 2020
Quick facts
| Lead sponsor | Corindus Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 242 |
| Start date | 12 April 2019 |
| Primary completion | 9 October 2020 |
| Estimated completion | 9 October 2020 |
| Sites | 8 locations across Japan |
Drugs / interventions tested
- Robotic-assisted PCI
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Corindus Inc.
Who can join
20 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath GRX System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters, and manipulation of guide catheters during PCI procedures in the first 231 patients treated with the CorPath device in Japan.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03870087
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Robotic-assisted PCI
Trials testing the same drug.
- NCT03278301 — PRECISION GRX Registry · completed
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Corindus Inc. trials
Trials by the same sponsor.
- NCT05634538 — The ROB-OSTIAL Study · NA · terminated
- NCT04883008 — NAVIGATE GRX Study · terminated
- NCT04459299 — CorPath GRX STEMI Study · terminated
- NCT04236856 — CorPath® GRX Neuro Study · NA · completed
- NCT03959072 — Cardiac Cath Lab Staff Radiation Exposure · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03870087 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Corindus Inc.
- Last refreshed: 19 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03870087.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing